Back

CRISPR/Cas9 gene editing for heart disease: ready for prime time? – discussion.

29 August 2021 (11:03 - 11:15)
Organised by:
Congress Presentation Part of: CRISPR/Cas9 gene editing for heart disease: ready for prime time? Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

4 More presentations in this session

Presentation thumbnail
Gene editing on its way to the clinics.
Professor E. McNally (Chicago, US)
Slides Video
Presentation thumbnail
Strategies to promote homology-directed repair in post-mitotic cardiomyocytes.
Associate Professor S. Higo (Osaka, JP)
Slides Video
Presentation thumbnail
Prime editing without double-strand breaks or donor DNA.
Presentation thumbnail
CRISPR/Cas9 gene editing for heart disease: ready for prime time? - Chat Moderator.

Access the full session

Session thumbnail
CRISPR/Cas9 gene editing for heart disease: ready for prime time?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 11:03 CET
You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources